ACONITUM NAP, ARSENICUM ALB, BORAX, CALC PHOS, GELSENIUM, LYCOPODIUM, PHOSPHORICUM AC, PICRICUM AC, PLUMB MET, SOLIDAGO

ACONITUM NAP, ARSENICUM ALB, BORAX, CALC PHOS, GELSENIUM, LYCOPODIUM, PHOSPHORICUM AC, PICRICUM AC, PLUMB MET, SOLIDAGO was reported 630 times

ACONITUM NAP, ARSENICUM ALB, BORAX, CALC PHOS, GELSENIUM, LYCOPODIUM, PHOSPHORICUM AC, PICRICUM AC, PLUMB MET, SOLIDAGO is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ACCESS SITE IRRITATION 1 0.3333
1 VENOUS OXYGEN PARTIAL PRESSURE INCREASED 1 0.1429
2 CAPNOGRAM ABNORMAL 1 0.1000
3 REMOVAL OF INERT MATTER FROM SKIN OR SUBCUTANEOUS TISSUE 1 0.0667
4 SECONDARY TRANSMISSION 1 0.0500
5 HUMAN CHORIONIC GONADOTROPIN NEGATIVE 1 0.0476
6 PANTOEA AGGLOMERANS INFECTION 3 0.0390
7 VACCINATION SITE INDURATION 1 0.0294
8 SCAR INFLAMMATION 1 0.0286
9 PIGMENTARY GLAUCOMA 1 0.0270
10 COMPLEMENT DEFICIENCY DISEASE 1 0.0270
11 WATER POLLUTION 1 0.0238
12 CATHETER SITE PHLEBITIS 1 0.0192
13 HAEMORRHOID INFECTION 1 0.0161
14 DEAFNESS PERMANENT 3 0.0153
15 ANAL HYPOAESTHESIA 1 0.0147
16 MIXED DEAFNESS 1 0.0127
17 INSTILLATION SITE SWELLING 2 0.0114
18 HYDROSALPINX 1 0.0109
19 THROMBOEMBOLECTOMY 1 0.0105
20 KLEBSIELLA TEST POSITIVE 6 0.0092
21 ENDOCRINE OPHTHALMOPATHY 8 0.0092
22 BILIRUBIN URINE PRESENT 1 0.0084
23 INSTILLATION SITE LACRIMATION 2 0.0083
24 PARATRACHEAL LYMPHADENOPATHY 1 0.0082
25 PERIARTHRITIS 16 0.0070
26 GLUCOSE URINE 1 0.0067
27 PALINDROMIC RHEUMATISM 1 0.0063
28 SUPERFICIAL VEIN THROMBOSIS 5 0.0059
29 INSTILLATION SITE PRURITUS 2 0.0053
30 POLYDIPSIA PSYCHOGENIC 1 0.0049
31 MALIGNANT MELANOMA STAGE 0 1 0.0048
32 PRODUCT INTOLERANCE 1 0.0045
33 CONGENITAL HIATUS HERNIA 1 0.0044
34 CENTRAL VENOUS CATHETER REMOVAL 2 0.0043
35 INSTILLATION SITE DISCHARGE 1 0.0038
36 INSTILLATION SITE ERYTHEMA 2 0.0038
37 RETINOGRAM ABNORMAL 1 0.0037
38 CHEMICAL BURNS OF EYE 1 0.0036
39 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
40 IMMATURE GRANULOCYTE COUNT INCREASED 1 0.0035
41 BINOCULAR EYE MOVEMENT DISORDER 1 0.0035
42 PRODUCT RECONSTITUTION QUALITY ISSUE 3 0.0034
43 CAUSTIC INJURY 1 0.0032
44 INCREASED DOSE ADMINISTERED 1 0.0032
45 CATHETER SITE SWELLING 3 0.0032
46 CORTISOL INCREASED 2 0.0032
47 VASCULAR COMPRESSION 1 0.0032
48 RADICULAR PAIN 1 0.0029
49 INFECTED DERMAL CYST 1 0.0028
50 NASAL TURBINATE HYPERTROPHY 1 0.0027
51 IMPLANT SITE IRRITATION 1 0.0026
52 RETINAL INJURY 2 0.0026
53 DIABETES INSIPIDUS 6 0.0025
54 MANUFACTURING MATERIALS ISSUE 1 0.0025
55 PROCEDURAL HEADACHE 1 0.0024
56 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 1 0.0023
57 REFLUX LARYNGITIS 1 0.0023
58 CERUMEN IMPACTION 2 0.0022
59 BRAIN DAMAGE 1 0.0020
60 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 1 0.0020
61 WATER INTOXICATION 1 0.0020
62 POSTICTAL STATE 2 0.0019
63 BLOOD PHOSPHORUS DECREASED 7 0.0019
64 PROCEDURAL SITE REACTION 1 0.0019
65 INFECTED FISTULA 1 0.0019
66 IRIS DISORDER 1 0.0019
67 BODY FAT DISORDER 1 0.0018
68 NEUROLOGIC NEGLECT SYNDROME 1 0.0018
69 FAECES HARD 7 0.0018
70 CARBOHYDRATE ANTIGEN 125 INCREASED 6 0.0018
71 CARBON DIOXIDE DECREASED 2 0.0017
72 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
73 PUPIL FIXED 3 0.0017
74 ENDOTRACHEAL INTUBATION COMPLICATION 1 0.0017
75 VITRECTOMY 1 0.0017
76 TETANY 3 0.0016
77 BRAIN DEATH 5 0.0016
78 BACILLUS INFECTION 1 0.0016
79 HYPERCHLORAEMIA 1 0.0016
80 CHALAZION 1 0.0016
81 TONIC CLONIC MOVEMENTS 2 0.0015
82 T-LYMPHOCYTE COUNT DECREASED 1 0.0015
83 PATIENT-DEVICE INCOMPATIBILITY 1 0.0015
84 SUTURE RELATED COMPLICATION 1 0.0014
85 GLASSY EYES 1 0.0014
86 HYPERNATRAEMIA 7 0.0014
87 PERINEAL PAIN 1 0.0014
88 BUNION 1 0.0014
89 DRUG-DISEASE INTERACTION 1 0.0014
90 TONGUE BLISTERING 3 0.0013
91 SENSITISATION 1 0.0013
92 MAMMOPLASTY 1 0.0013
93 PROCEDURAL NAUSEA 1 0.0012
94 CARTILAGE ATROPHY 1 0.0012
95 DEAFNESS NEUROSENSORY 4 0.0012
96 NEONATAL HYPOXIA 1 0.0012
97 HEPATITIS A 1 0.0012
98 TREATMENT DELAYED 2 0.0012
99 SPINAL CORD NEOPLASM 1 0.0011
100 EXTREMITY NECROSIS 2 0.0011
101 ARTERIAL STENOSIS 1 0.0011
102 DRUG LEVEL FLUCTUATING 1 0.0011
103 PROTEIN URINE 1 0.0011
104 BODY TEMPERATURE ABNORMAL 2 0.0011
105 PRODUCT APPEARANCE CONFUSION 1 0.0011
106 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 1 0.0011
107 PHARYNGEAL HYPOAESTHESIA 1 0.0011
108 INTRACRANIAL PRESSURE INCREASED 6 0.0011
109 VENOUS INJURY 1 0.0011
110 RED BLOOD CELL ABNORMALITY 1 0.0010
111 EYELID MARGIN CRUSTING 3 0.0010
112 RALES 6 0.0010
113 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
114 BRAIN STEM INFARCTION 1 0.0010
115 POLYCYTHAEMIA 2 0.0010
116 POOR QUALITY PRODUCT ADMINISTERED 10 0.0009
117 INNER EAR DISORDER 1 0.0009
118 CATHETER SITE ERYTHEMA 2 0.0009
119 IDIOPATHIC URTICARIA 1 0.0009
120 EXOPHTHALMOS 2 0.0009
121 RHEUMATOID FACTOR INCREASED 1 0.0009
122 OPEN WOUND 1 0.0009
123 MYOCARDIAL INJURY 1 0.0009
124 SUBCLAVIAN VEIN THROMBOSIS 1 0.0009
125 CHEMICAL BURN 1 0.0009
126 SYNOVIAL CYST 4 0.0009
127 BLADDER OPERATION 1 0.0009
128 ALLODYNIA 1 0.0009
129 DEFAECATION URGENCY 6 0.0009
130 INSTILLATION SITE IRRITATION 1 0.0008
131 INSTILLATION SITE PAIN 2 0.0008
132 INTERVERTEBRAL DISC OPERATION 1 0.0008
133 BLOOD UREA DECREASED 1 0.0008
134 ALLERGY TO CHEMICALS 1 0.0008
135 PRODUCT USED FOR UNKNOWN INDICATION 1 0.0008
136 FISTULA DISCHARGE 1 0.0008
137 CATHETER SITE PAIN 2 0.0008
138 PERIORBITAL OEDEMA 4 0.0008
139 LIP INJURY 1 0.0008
140 FOREIGN BODY IN RESPIRATORY TRACT 1 0.0008
141 VULVOVAGINAL CANDIDIASIS 1 0.0007
142 CORNEAL ABRASION 1 0.0007
143 HEAD TITUBATION 1 0.0007
144 PLEURITIC PAIN 2 0.0007
145 MAST CELL ACTIVATION SYNDROME 1 0.0007
146 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
147 UTERINE RUPTURE 1 0.0007
148 BLOOD MAGNESIUM DECREASED 6 0.0007
149 STOMA SITE PAIN 1 0.0007
150 PHYSICAL DISABILITY 3 0.0007
151 BRAIN HERNIATION 2 0.0007
152 BLOOD PRESSURE IMMEASURABLE 1 0.0007
153 STOMA SITE HAEMORRHAGE 1 0.0006
154 VASCULAR RUPTURE 1 0.0006
155 INFERTILITY FEMALE 1 0.0006
156 PRODUCT DEPOSIT 1 0.0006
157 INFUSION SITE SWELLING 4 0.0006
158 ANALGESIC DRUG LEVEL INCREASED 1 0.0006
159 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
160 COSTOCHONDRITIS 1 0.0006
161 OROPHARYNGEAL BLISTERING 1 0.0006
162 MUCOUS STOOLS 3 0.0006
163 ELECTROLYTE IMBALANCE 7 0.0006
164 VEIN RUPTURE 1 0.0006
165 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
166 INFUSION SITE ERYTHEMA 5 0.0006
167 TONGUE ULCERATION 2 0.0006
168 SKIN WOUND 1 0.0006
169 GAZE PALSY 1 0.0006
170 BLOOD CHLORIDE INCREASED 1 0.0006
171 OTORRHOEA 1 0.0006
172 INFUSION SITE DISCHARGE 1 0.0006
173 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
174 HYPERCALCAEMIA 7 0.0006
175 JOINT ARTHROPLASTY 1 0.0006
176 PRODUCT TAMPERING 1 0.0006
177 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
178 GRANULOCYTE COUNT DECREASED 1 0.0005
179 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
180 TRAUMATIC LUNG INJURY 1 0.0005
181 NASAL SEPTUM DEVIATION 1 0.0005
182 COLOSTOMY 1 0.0005
183 HYPERAEMIA 1 0.0005
184 MUCOSAL DRYNESS 1 0.0005
185 MUSCLE CONTRACTURE 1 0.0005
186 PERIPHERAL VENOUS DISEASE 2 0.0005
187 CHANGE OF BOWEL HABIT 1 0.0005
188 EXTRAVASATION 2 0.0005
189 QUADRIPLEGIA 1 0.0005
190 VENOUS THROMBOSIS LIMB 1 0.0005
191 INSULIN RESISTANCE 1 0.0005
192 BRAIN OEDEMA 6 0.0005
193 EYE CONTUSION 1 0.0005
194 INJECTION SITE IRRITATION 6 0.0005
195 MYDRIASIS 6 0.0005
196 CD4 LYMPHOCYTES DECREASED 1 0.0005
197 PROCTALGIA 3 0.0005
198 HYPERPHOSPHATAEMIA 1 0.0005
199 INFUSION SITE BRUISING 1 0.0005
200 IMMOBILE 2 0.0005
201 PRODUCT PREPARATION ISSUE 3 0.0005
202 LARGE INTESTINAL OBSTRUCTION 1 0.0004
203 PRODUCT USE COMPLAINT 7 0.0004
204 WRONG PRODUCT ADMINISTERED 3 0.0004
205 PUSTULE 1 0.0004
206 VOLVULUS 1 0.0004
207 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1 0.0004
208 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
209 VARICELLA 1 0.0004
210 IMPAIRED QUALITY OF LIFE 6 0.0004
211 WRONG DOSE 1 0.0004
212 PRODUCT PACKAGING CONFUSION 1 0.0004
213 BRONCHITIS CHRONIC 1 0.0004
214 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
215 EAR DISCOMFORT 4 0.0004
216 MEAN CELL VOLUME INCREASED 1 0.0004
217 MENOPAUSE 1 0.0004
218 BLOOD CHLORIDE DECREASED 1 0.0004
219 VARICOSE VEIN 2 0.0004
220 COMPARTMENT SYNDROME 1 0.0004
221 ABDOMINAL MASS 1 0.0004
222 EAR CONGESTION 1 0.0004
223 STOMA SITE DISCHARGE 1 0.0004
224 WOUND INFECTION 4 0.0004
225 RHEUMATOID NODULE 1 0.0004
226 BLOOD UREA INCREASED 6 0.0004
227 PRODUCT LEAKAGE 2 0.0004
228 SKIN HYPERTROPHY 1 0.0004
229 RESPIRATORY SYMPTOM 1 0.0004
230 LIP PAIN 1 0.0003
231 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
232 BACTERAEMIA 4 0.0003
233 URINE ANALYSIS ABNORMAL 1 0.0003
234 BLOOD CULTURE POSITIVE 1 0.0003
235 METABOLIC ENCEPHALOPATHY 1 0.0003
236 MIXED LIVER INJURY 1 0.0003
237 ACNE CYSTIC 1 0.0003
238 CENTRAL VENOUS CATHETERISATION 1 0.0003
239 THROMBOPHLEBITIS SUPERFICIAL 1 0.0003
240 EYE INJURY 1 0.0003
241 IRITIS 1 0.0003
242 DYSCHEZIA 1 0.0003
243 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
244 MULTIPLE-DRUG RESISTANCE 1 0.0003
245 HEPATIC CIRRHOSIS 6 0.0003
246 BLOOD CREATININE DECREASED 1 0.0003
247 SWELLING OF EYELID 2 0.0003
248 BREAST CANCER RECURRENT 1 0.0003
249 BLADDER PAIN 1 0.0003
250 ERUCTATION 6 0.0003
251 LYMPHOCYTE COUNT INCREASED 1 0.0003
252 INJECTION SITE INFECTION 1 0.0003
253 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
254 CANDIDA INFECTION 5 0.0003
255 NEOPLASM RECURRENCE 1 0.0003
256 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
257 NEUTROPHIL COUNT INCREASED 3 0.0003
258 EYE MOVEMENT DISORDER 2 0.0003
259 PRODUCT PREPARATION ERROR 6 0.0003
260 PERIPHERAL COLDNESS 4 0.0003
261 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
262 POOR VENOUS ACCESS 3 0.0003
263 EYE DISCHARGE 3 0.0003
264 MICTURITION DISORDER 1 0.0003
265 HYPOPNOEA 1 0.0003
266 EAR PRURITUS 1 0.0003
267 HYPONATRAEMIA 16 0.0003
268 HEREDITARY ANGIOEDEMA 3 0.0003
269 DEVICE KINK 1 0.0003
270 SEBORRHOEA 1 0.0003
271 HAEMATOCHEZIA 15 0.0003
272 RECTAL DISCHARGE 1 0.0003
273 HEPATOTOXICITY 6 0.0003
274 TENDON INJURY 1 0.0003
275 BLOOD POTASSIUM DECREASED 8 0.0003
276 CATHETER SITE INFECTION 1 0.0003
277 PROCEDURAL COMPLICATION 2 0.0003
278 APNOEA 2 0.0003
279 ORAL INFECTION 1 0.0003
280 POLYDIPSIA 1 0.0003
281 IDIOPATHIC PULMONARY FIBROSIS 1 0.0003
282 MYELOSUPPRESSION 9 0.0002
283 APPLICATION SITE DISCOLOURATION 1 0.0002
284 LEG AMPUTATION 1 0.0002
285 ONYCHOMADESIS 1 0.0002
286 HEPATITIS 6 0.0002
287 SHOULDER OPERATION 1 0.0002
288 ABNORMAL SENSATION IN EYE 1 0.0002
289 CHAPPED LIPS 1 0.0002
290 TUMOUR LYSIS SYNDROME 2 0.0002
291 PRODUCT COMMUNICATION ISSUE 2 0.0002
292 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
293 GASTROINTESTINAL INFECTION 2 0.0002
294 JAUNDICE 6 0.0002
295 VASCULAR DEVICE INFECTION 1 0.0002
296 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
297 CYSTITIS 7 0.0002
298 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
299 INCREASED TENDENCY TO BRUISE 2 0.0002
300 EYE OPERATION 1 0.0002
301 PRODUCT DISTRIBUTION ISSUE 2 0.0002
302 CHOLELITHIASIS 7 0.0002
303 SPINAL COLUMN STENOSIS 1 0.0002
304 SUBCUTANEOUS ABSCESS 1 0.0002
305 LIMB OPERATION 1 0.0002
306 AFFECT LABILITY 2 0.0002
307 EAR PAIN 4 0.0002
308 VITAMIN D DEFICIENCY 2 0.0002
309 HORMONE LEVEL ABNORMAL 1 0.0002
310 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
311 BREATH SOUNDS ABNORMAL 1 0.0002
312 HYPERVOLAEMIA 1 0.0002
313 HAEMATOCRIT DECREASED 4 0.0002
314 BLADDER DISORDER 2 0.0002
315 SALIVARY HYPERSECRETION 2 0.0002
316 HYPOXIA 7 0.0002
317 DYSPHORIA 1 0.0002
318 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
319 PRODUCT COLOUR ISSUE 1 0.0002
320 INCREASED UPPER AIRWAY SECRETION 1 0.0002
321 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
322 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
323 FAILURE TO THRIVE 1 0.0002
324 DRUG-INDUCED LIVER INJURY 6 0.0002
325 RENAL PAIN 2 0.0002
326 ANAL FISTULA 1 0.0002
327 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
328 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
329 BRUXISM 1 0.0002
330 PHARYNGITIS STREPTOCOCCAL 2 0.0002
331 ASTHENOPIA 1 0.0002
332 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
333 DISCOMFORT 11 0.0002
334 ANGIOPATHY 1 0.0002
335 BLOOD CALCIUM DECREASED 2 0.0002
336 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
337 EYE INFECTION 2 0.0002
338 PERIORBITAL SWELLING 1 0.0002
339 PERONEAL NERVE PALSY 1 0.0002
340 NEUTROPHILIA 1 0.0002
341 INTENTIONAL DOSE OMISSION 5 0.0002
342 CHOLECYSTECTOMY 2 0.0002
343 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
344 NEUROLOGICAL SYMPTOM 1 0.0002
345 TINNITUS 8 0.0002
346 JOINT SWELLING 21 0.0002
347 MOUTH SWELLING 1 0.0002
348 BLOOD URIC ACID INCREASED 1 0.0002
349 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
350 ABDOMINAL DISTENSION 18 0.0002
351 SKIN WARM 1 0.0002
352 HYPOVOLAEMIA 1 0.0002
353 DECREASED INTEREST 1 0.0002
354 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
355 CATARACT OPERATION 1 0.0002
356 HEPATITIS B 1 0.0002
357 INJECTION SITE VESICLES 1 0.0002
358 DERMATITIS ACNEIFORM 1 0.0002
359 CYTOPENIA 2 0.0002
360 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
361 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
362 PRE-EXISTING CONDITION IMPROVED 1 0.0002
363 PNEUMONIA ASPIRATION 4 0.0002
364 SWOLLEN TONGUE 5 0.0002
365 HAEMATEMESIS 4 0.0002
366 CARDIOVASCULAR DISORDER 4 0.0002
367 FOREIGN BODY SENSATION IN EYES 1 0.0002
368 ENTERITIS 1 0.0002
369 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
370 HAEMOGLOBIN ABNORMAL 1 0.0002
371 UNRESPONSIVE TO STIMULI 4 0.0002
372 HERPES SIMPLEX 1 0.0002
373 ORAL CANDIDIASIS 2 0.0002
374 DYSGRAPHIA 1 0.0002
375 WALKING AID USER 1 0.0002
376 SINUS DISORDER 3 0.0002
377 SARS-COV-2 TEST POSITIVE 2 0.0002
378 APPETITE DISORDER 1 0.0002
379 EAR INFECTION 4 0.0002
380 TERMINAL STATE 1 0.0001
381 BRONCHIECTASIS 1 0.0001
382 PALLOR 4 0.0001
383 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
384 BLOOD TESTOSTERONE DECREASED 1 0.0001
385 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
386 ONYCHOCLASIS 1 0.0001
387 RESPIRATION ABNORMAL 1 0.0001
388 HYPOMAGNESAEMIA 2 0.0001
389 EXTRASYSTOLES 1 0.0001
390 BURNING SENSATION 10 0.0001
391 DEVICE OCCLUSION 2 0.0001
392 THERMAL BURN 1 0.0001
393 FEAR OF INJECTION 1 0.0001
394 TONGUE DISORDER 1 0.0001
395 MENTAL DISORDER 6 0.0001
396 HYPOKINESIA 2 0.0001
397 PRODUCT PRESCRIBING ISSUE 3 0.0001
398 FAECES SOFT 1 0.0001
399 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
400 MOUTH HAEMORRHAGE 1 0.0001
401 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
402 HYPOPHOSPHATAEMIA 1 0.0001
403 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
404 ARTHROPOD BITE 1 0.0001
405 HAEMORRHAGE INTRACRANIAL 2 0.0001
406 DYSARTHRIA 5 0.0001
407 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
408 AORTIC ANEURYSM 1 0.0001
409 TROPONIN INCREASED 1 0.0001
410 BOWEL MOVEMENT IRREGULARITY 1 0.0001
411 DISSOCIATION 1 0.0001
412 OEDEMA 7 0.0001
413 HAEMORRHAGIC STROKE 1 0.0001
414 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
415 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
416 OCULAR HYPERAEMIA 6 0.0001
417 FURUNCLE 1 0.0001
418 BLOOD ALBUMIN DECREASED 1 0.0001
419 MEDICATION ERROR 7 0.0001
420 HYPOTHYROIDISM 4 0.0001
421 MYASTHENIA GRAVIS 1 0.0001
422 SHOCK HAEMORRHAGIC 1 0.0001
423 DECUBITUS ULCER 1 0.0001
424 NEUTROPHIL COUNT DECREASED 5 0.0001
425 HYPERAESTHESIA 1 0.0001
426 EYE IRRITATION 7 0.0001
427 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
428 MENSTRUAL DISORDER 1 0.0001
429 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
430 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
431 LIVE BIRTH 1 0.0001
432 PRODUCT CONTAINER ISSUE 1 0.0001
433 MUSCLE STRAIN 1 0.0001
434 CARDIAC MURMUR 1 0.0001
435 NAIL DISORDER 1 0.0001
436 BLOOD CALCIUM INCREASED 1 0.0001
437 GROIN PAIN 1 0.0001
438 SPINAL OSTEOARTHRITIS 1 0.0001
439 GRIP STRENGTH DECREASED 1 0.0001
440 LYMPHADENOPATHY 4 0.0001
441 HEAD DISCOMFORT 2 0.0001
442 RESPIRATORY RATE INCREASED 1 0.0001
443 WRONG DRUG ADMINISTERED 1 0.0001
444 ANAL INCONTINENCE 1 0.0001
445 BLOOD BILIRUBIN INCREASED 3 0.0001
446 EXOSTOSIS 1 0.0001
447 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
448 AGRANULOCYTOSIS 2 0.0001
449 EYE SWELLING 4 0.0001
450 ERYTHEMA MULTIFORME 1 0.0001
451 BLOOD CREATININE INCREASED 7 0.0001
452 BACTERIAL INFECTION 2 0.0001
453 HALLUCINATION 8 0.0001
454 BLOOD SODIUM DECREASED 2 0.0001
455 DYSPHAGIA 10 0.0001
456 BLOOD PRESSURE DECREASED 7 0.0001
457 RECALLED PRODUCT ADMINISTERED 1 0.0001
458 HYPERCHOLESTEROLAEMIA 1 0.0001
459 HAEMORRHOIDS 2 0.0001
460 KIDNEY INFECTION 2 0.0001
461 VITREOUS FLOATERS 1 0.0001
462 BODY TEMPERATURE DECREASED 1 0.0001
463 UPPER LIMB FRACTURE 2 0.0001
464 AGGRESSION 5 0.0001
465 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
466 PRODUCT ADMINISTRATION ERROR 2 0.0001
467 SEPSIS 11 0.0001
468 FLUID RETENTION 5 0.0001
469 TOOTH ABSCESS 1 0.0001
470 MOTOR DYSFUNCTION 1 0.0001
471 SLUGGISHNESS 1 0.0001
472 EUPHORIC MOOD 1 0.0001
473 PERIPHERAL SWELLING 15 0.0001
474 TENDERNESS 1 0.0001
475 PETECHIAE 1 0.0001
476 PRODUCT ODOUR ABNORMAL 1 0.0001
477 MOUTH ULCERATION 2 0.0001
478 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
479 SCRATCH 1 0.0001
480 INCONTINENCE 1 0.0001
481 FULL BLOOD COUNT ABNORMAL 1 0.0001
482 SUDDEN DEATH 1 0.0001
483 BODY HEIGHT DECREASED 1 0.0001
484 DRUG INTOLERANCE 9 0.0001
485 RECTAL HAEMORRHAGE 4 0.0001
486 HYPOACUSIS 4 0.0001
487 DECREASED ACTIVITY 1 0.0001
488 PRURITUS GENERALISED 2 0.0001
489 SWELLING FACE 6 0.0001
490 INJECTION SITE SWELLING 7 0.0001
491 ASPIRATION 1 0.0001
492 EYE DISORDER 3 0.0001
493 GASTROINTESTINAL PAIN 1 0.0001
494 DENTAL CARIES 1 0.0001
495 FOOT DEFORMITY 1 0.0001
496 TACHYCARDIA 8 0.0001
497 RASH MACULO-PAPULAR 2 0.0001
498 EYE PRURITUS 3 0.0001
499 RASH PAPULAR 2 0.0001
500 SKIN INFECTION 1 0.0001
501 FISTULA 1 0.0001
502 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
503 VISUAL IMPAIRMENT 11 0.0001
504 STATUS EPILEPTICUS 1 0.0001
505 MITRAL VALVE INCOMPETENCE 1 0.0001
506 MYOCARDIAL ISCHAEMIA 1 0.0001
507 PRODUCT AVAILABILITY ISSUE 2 0.0001
508 MICTURITION URGENCY 1 0.0001
509 INTERNAL HAEMORRHAGE 1 0.0001
510 MYOCARDITIS 1 0.0001
511 SHOCK 2 0.0001
512 METASTASES TO LUNG 1 0.0001
513 DRY MOUTH 7 0.0001
514 SWELLING 8 0.0001
515 SEXUAL DYSFUNCTION 1 0.0001
516 COVID-19 PNEUMONIA 1 0.0001
517 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
518 PRODUCTIVE COUGH 4 0.0001
519 HYPERLIPIDAEMIA 1 0.0001
520 RASH ERYTHEMATOUS 4 0.0001
521 WRIST FRACTURE 1 0.0001
522 HEPATITIS C 1 0.0001
523 ADRENAL INSUFFICIENCY 1 0.0001
524 WEIGHT DECREASED 23 0.0001
525 ABDOMINAL PAIN 19 0.0001
526 PRODUCT DOSE OMISSION ISSUE 24 0.0001
527 MUSCLE SPASTICITY 1 0.0001
528 DYSPEPSIA 8 0.0001
529 GENERALISED OEDEMA 1 0.0001
530 HEART RATE INCREASED 8 0.0001
531 INJECTION SITE ERYTHEMA 10 0.0001
532 CONFUSIONAL STATE 13 0.0001
533 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
534 SECRETION DISCHARGE 1 0.0001
535 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
536 SINUSITIS 8 0.0001
537 INFUSION SITE PAIN 1 0.0001
538 SKIN ULCER 2 0.0001
539 PLASMA CELL MYELOMA 3 0.0001
540 NODULE 1 0.0001
541 MUSCULOSKELETAL PAIN 4 0.0001
542 SPEECH DISORDER 4 0.0001
543 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
544 GASTRITIS 2 0.0001
545 INFECTION 11 0.0001
546 IMMUNE SYSTEM DISORDER 1 0.0001
547 PULMONARY CONGESTION 1 0.0001
548 DYSMENORRHOEA 1 0.0001
549 PYREXIA 26 0.0001
550 THROMBOSIS 6 0.0001
551 EMOTIONAL DISTRESS 9 0.0001
552 SINUS CONGESTION 1 0.0001
553 PRODUCT TASTE ABNORMAL 1 0.0001
554 UVEITIS 1 0.0001
555 LIMB INJURY 2 0.0001
556 BLINDNESS 3 0.0001
557 TACHYPNOEA 1 0.0001
558 RESPIRATORY DISTRESS 2 0.0001
559 ORAL DISCOMFORT 1 0.0001
560 HAEMOPTYSIS 2 0.0001
561 COORDINATION ABNORMAL 1 0.0001
562 URTICARIA 12 0.0001
563 MASS 1 0.0001
564 BLOOD TEST ABNORMAL 1 0.0001
565 SKIN EXFOLIATION 6 0.0001
566 BLINDNESS UNILATERAL 1 0.0001
567 ASTHMA 8 0.0001
568 FLATULENCE 4 0.0001
569 PARALYSIS 1 0.0001
570 SOMNOLENCE 14 0.0001
571 BALANCE DISORDER 6 0.0001
572 SEIZURE 8 0.0001
573 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
574 FALL 23 0.0001
575 DYSSTASIA 2 0.0001
576 CHEST DISCOMFORT 7 0.0001
577 PALPITATIONS 8 0.0001
578 HAEMOGLOBIN DECREASED 7 0.0001
579 PSYCHOTIC DISORDER 2 0.0001
580 SKIN HAEMORRHAGE 1 0.0001
581 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
582 HYPOAESTHESIA 10 0.0001
583 IRRITABILITY 4 0.0001
584 NO ADVERSE EVENT 12 0.0001
585 APHASIA 2 0.0001
586 LACRIMATION INCREASED 2 0.0001
587 CORONARY ARTERY DISEASE 2 0.0001
588 OEDEMA PERIPHERAL 8 0.0001
589 INSURANCE ISSUE 1 0.0001
590 SKIN DISCOLOURATION 3 0.0001
591 FEELING HOT 4 0.0001
592 INJECTION SITE RASH 2 0.0001
593 PHARYNGEAL OEDEMA 1 0.0001
594 DEVICE RELATED INFECTION 1 0.0001
595 MUSCULOSKELETAL CHEST PAIN 1 0.0001
596 ANKLE FRACTURE 1 0.0001
597 TENDONITIS 1 0.0001
598 LUNG INFECTION 1 0.0001
599 COGNITIVE DISORDER 3 0.0001
600 CONSTIPATION 14 0.0001
601 NERVOUS SYSTEM DISORDER 2 0.0001
602 BRAIN FOG 1 0.0001
603 HEAD INJURY 2 0.0001
604 PNEUMOTHORAX 1 0.0001
605 ULCER 1 0.0001
606 MULTIPLE SCLEROSIS 3 0.0001
607 ABSCESS 1 0.0001
608 HIP FRACTURE 2 0.0001
609 HYPOGLYCAEMIA 3 0.0001
610 MUSCLE TIGHTNESS 1 0.0001
611 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
612 DRUG LEVEL INCREASED 1 0.0001
613 DECREASED APPETITE 14 0.0001
614 VISUAL ACUITY REDUCED 2 0.0001
615 EXPIRED PRODUCT ADMINISTERED 2 0.0001
616 LIP SWELLING 2 0.0001
617 FUNGAL INFECTION 2 0.0001
618 SYNCOPE 6 0.0001
619 CHILLS 7 0.0001
620 VOMITING 28 0.0001
621 CELLULITIS 3 0.0001
622 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
623 MALAISE 26 0.0001
624 ANGER 2 0.0001
625 HEMIPARESIS 1 0.0001
626 PAIN 36 0.0001
627 SCAR 1 0.0001
628 HAEMATURIA 2 0.0001
629 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
630 DYSPNOEA 33 0.0001
631 ILLNESS 6 0.0001
632 INJECTION SITE REACTION 4 0.0001
633 PARANOIA 1 0.0001
634 PRODUCT STORAGE ERROR 5 0.0001
635 EOSINOPHILIA 1 0.0001
636 LYMPHOCYTE COUNT DECREASED 1 0.0001
637 BRADYCARDIA 3 0.0001
638 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
639 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
640 GOUT 1 0.0001
641 MOBILITY DECREASED 4 0.0001
642 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
643 LEUKOCYTOSIS 1 0.0001
644 TOOTHACHE 1 0.0001
645 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
646 PELVIC PAIN 1 0.0001
647 CRYING 2 0.0001
648 HYPERGLYCAEMIA 2 0.0001
649 RESPIRATORY FAILURE 4 0.0001
650 TREATMENT NONCOMPLIANCE 3 0.0001
651 END STAGE RENAL DISEASE 1 0.0001
652 PRURITUS 21 0.0001
653 SUICIDAL IDEATION 5 0.0001
654 MUSCLE SPASMS 10 0.0001
655 FATIGUE 42 0.0001
656 CONJUNCTIVITIS 1 0.0001
657 PANCYTOPENIA 3 0.0001
658 OXYGEN SATURATION DECREASED 3 0.0001
659 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
660 MUSCULAR WEAKNESS 6 0.0001
661 BLOOD URINE PRESENT 1 0.0001
662 GASTRIC ULCER 1 0.0001
663 PROTEINURIA 1 0.0001
664 INSOMNIA 14 0.0001
665 DEHYDRATION 7 0.0001
666 CONVULSION 3 0.0001
667 BLOOD PRESSURE INCREASED 8 0.0001
668 LETHARGY 3 0.0001
669 HYPERTENSION 11 0.0001
670 GLAUCOMA 1 0.0001
671 HERNIA 1 0.0001
672 PRESCRIBED OVERDOSE 1 0.0001
673 PRODUCT QUALITY ISSUE 7 0.0001
674 ATRIAL FIBRILLATION 5 0.0001
675 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
676 ORAL HERPES 1 0.0001
677 BONE PAIN 3 0.0001
678 WHEEZING 3 0.0001
679 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
680 DISORIENTATION 2 0.0001
681 BLOOD PRESSURE ABNORMAL 1 0.0001
682 COUGH 14 0.0000
683 PRODUCT PHYSICAL ISSUE 1 0.0000
684 CONDITION AGGRAVATED 15 0.0000
685 ANXIETY 14 0.0000
686 BODY TEMPERATURE INCREASED 1 0.0000
687 INJECTION SITE PAIN 15 0.0000
688 OSTEOPOROSIS 2 0.0000
689 RIB FRACTURE 1 0.0000
690 HYPERSENSITIVITY 9 0.0000
691 TREMOR 8 0.0000
692 PAIN IN EXTREMITY 14 0.0000
693 KNEE ARTHROPLASTY 1 0.0000
694 HALLUCINATION, VISUAL 1 0.0000
695 PLATELET COUNT DECREASED 5 0.0000
696 JOINT INJURY 1 0.0000
697 IMPAIRED WORK ABILITY 1 0.0000
698 IRRITABLE BOWEL SYNDROME 1 0.0000
699 POOR QUALITY SLEEP 1 0.0000
700 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
701 ACUTE KIDNEY INJURY 7 0.0000
702 INTENTIONAL PRODUCT MISUSE 4 0.0000
703 ANGIOEDEMA 2 0.0000
704 LIVER DISORDER 2 0.0000
705 TRANSAMINASES INCREASED 1 0.0000
706 TOOTH DISORDER 1 0.0000
707 INFLUENZA 5 0.0000
708 COLITIS ULCERATIVE 2 0.0000
709 GLOSSODYNIA 1 0.0000
710 ORAL PAIN 1 0.0000
711 WEIGHT INCREASED 10 0.0000
712 GASTROINTESTINAL DISORDER 4 0.0000
713 ADVERSE DRUG REACTION 4 0.0000
714 PANCREATITIS ACUTE 1 0.0000
715 CHROMATURIA 1 0.0000
716 DRUG INTERACTION 7 0.0000
717 VISION BLURRED 6 0.0000
718 MUSCLE TWITCHING 1 0.0000
719 OROPHARYNGEAL PAIN 4 0.0000
720 DEVICE MALFUNCTION 3 0.0000
721 ARRHYTHMIA 2 0.0000
722 DISEASE RECURRENCE 2 0.0000
723 PRODUCT PRESCRIBING ERROR 1 0.0000
724 THERAPY INTERRUPTED 3 0.0000
725 MIGRAINE 4 0.0000
726 FEELING ABNORMAL 10 0.0000
727 NAUSEA 33 0.0000
728 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
729 CONTUSION 4 0.0000
730 HEADACHE 26 0.0000
731 MENTAL IMPAIRMENT 1 0.0000
732 FIBROMYALGIA 1 0.0000
733 NEURALGIA 1 0.0000
734 LUNG DISORDER 2 0.0000
735 ABASIA 1 0.0000
736 DYSGEUSIA 3 0.0000
737 DIARRHOEA 26 0.0000
738 PNEUMONIA 13 0.0000
739 EPISTAXIS 3 0.0000
740 COVID-19 7 0.0000
741 ABDOMINAL PAIN LOWER 1 0.0000
742 DIABETES MELLITUS 3 0.0000
743 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
744 ANAPHYLACTIC SHOCK 1 0.0000
745 INFLAMMATION 2 0.0000
746 HAEMATOMA 1 0.0000
747 EXPOSURE VIA SKIN CONTACT 1 0.0000
748 DIPLOPIA 1 0.0000
749 RESPIRATORY TRACT INFECTION 1 0.0000
750 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
751 PSORIASIS 5 0.0000
752 DEAFNESS 1 0.0000
753 SEDATION 1 0.0000
754 ARTHRITIS 3 0.0000
755 JOINT STIFFNESS 1 0.0000
756 DEPRESSED MOOD 2 0.0000
757 DRY SKIN 5 0.0000
758 CARDIAC FAILURE 3 0.0000
759 PRODUCT USE ISSUE 7 0.0000
760 FEAR 1 0.0000
761 DISTURBANCE IN ATTENTION 2 0.0000
762 FREQUENT BOWEL MOVEMENTS 1 0.0000
763 RASH 16 0.0000
764 GAIT DISTURBANCE 7 0.0000
765 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
766 RESPIRATORY ARREST 1 0.0000
767 DIVERTICULITIS 1 0.0000
768 MENTAL STATUS CHANGES 1 0.0000
769 ARTHROPATHY 2 0.0000
770 FEELING COLD 1 0.0000
771 ALOPECIA 7 0.0000
772 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
773 CEREBROVASCULAR ACCIDENT 6 0.0000
774 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
775 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
776 ANGINA PECTORIS 1 0.0000
777 HYPERSOMNIA 1 0.0000
778 HERPES ZOSTER 2 0.0000
779 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
780 ASTHENIA 13 0.0000
781 BACK PAIN 8 0.0000
782 LIVER FUNCTION TEST ABNORMAL 1 0.0000
783 MUSCULOSKELETAL STIFFNESS 3 0.0000
784 DYSPHONIA 2 0.0000
785 DIZZINESS 17 0.0000
786 ERYTHEMA 7 0.0000
787 NASAL CONGESTION 2 0.0000
788 LABORATORY TEST ABNORMAL 1 0.0000
789 URINARY INCONTINENCE 1 0.0000
790 ARTHRALGIA 14 0.0000
791 RESPIRATORY DISORDER 1 0.0000
792 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
793 THERAPEUTIC RESPONSE DECREASED 2 0.0000
794 DRUG ADMINISTRATION ERROR 1 0.0000
795 ADVERSE EVENT 3 0.0000
796 NASOPHARYNGITIS 6 0.0000
797 EMOTIONAL DISORDER 1 0.0000
798 GYNAECOMASTIA 1 0.0000
799 PRODUCT USE IN UNAPPROVED INDICATION 8 0.0000
800 EXPOSURE DURING PREGNANCY 2 0.0000
801 OFF LABEL USE 28 0.0000
802 BLOOD GLUCOSE INCREASED 6 0.0000
803 NEUROPATHY PERIPHERAL 3 0.0000
804 MOVEMENT DISORDER 1 0.0000
805 HYPERHIDROSIS 4 0.0000
806 NIGHT SWEATS 1 0.0000
807 AMNESIA 2 0.0000
808 IMPAIRED HEALING 1 0.0000
809 STAPHYLOCOCCAL INFECTION 1 0.0000
810 VIRAL INFECTION 1 0.0000
811 SKIN DISORDER 1 0.0000
812 URINARY RETENTION 1 0.0000
813 INJECTION SITE PRURITUS 2 0.0000
814 ABDOMINAL DISCOMFORT 5 0.0000
815 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
816 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
817 HEPATIC ENZYME INCREASED 2 0.0000
818 NIGHTMARE 1 0.0000
819 HYPERKALAEMIA 1 0.0000
820 INJURY 2 0.0000
821 SLEEP DISORDER 2 0.0000
822 PRODUCT ADHESION ISSUE 1 0.0000
823 C-REACTIVE PROTEIN INCREASED 1 0.0000
824 PANIC ATTACK 1 0.0000
825 ACCIDENTAL OVERDOSE 1 0.0000
826 RESTLESSNESS 1 0.0000
827 AGITATION 2 0.0000
828 DYSURIA 1 0.0000
829 INJECTION SITE MASS 1 0.0000
830 BRONCHITIS 2 0.0000
831 CHEST PAIN 5 0.0000
832 HEPATIC FUNCTION ABNORMAL 1 0.0000
833 DEATH 23 0.0000
834 DYSPNOEA EXERTIONAL 1 0.0000
835 INTESTINAL OBSTRUCTION 1 0.0000
836 COLITIS 1 0.0000
837 ANAEMIA 5 0.0000
838 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
839 HOSPITALISATION 4 0.0000
840 DRUG DOSE OMISSION BY DEVICE 2 0.0000
841 PARAESTHESIA 4 0.0000
842 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
843 INJECTION SITE BRUISING 2 0.0000
844 INJECTION SITE HAEMORRHAGE 2 0.0000
845 EXTRA DOSE ADMINISTERED 1 0.0000
846 PSORIATIC ARTHROPATHY 1 0.0000
847 DEVICE BREAKAGE 1 0.0000
848 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
849 CARDIAC ARREST 2 0.0000
850 DRUG ABUSE 2 0.0000
851 RHABDOMYOLYSIS 1 0.0000
852 CARDIO-RESPIRATORY ARREST 1 0.0000
853 WITHDRAWAL SYNDROME 1 0.0000
854 RENAL IMPAIRMENT 2 0.0000
855 OSTEOARTHRITIS 1 0.0000
856 RENAL FAILURE ACUTE 1 0.0000
857 URINARY TRACT INFECTION 4 0.0000
858 LOSS OF CONSCIOUSNESS 3 0.0000
859 SEPTIC SHOCK 1 0.0000
860 DRUG WITHDRAWAL SYNDROME 2 0.0000
861 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
862 DEVICE ISSUE 2 0.0000
863 THROAT IRRITATION 1 0.0000
864 INCORRECT DOSE ADMINISTERED 5 0.0000
865 MEMORY IMPAIRMENT 3 0.0000
866 NEPHROLITHIASIS 1 0.0000
867 HYPOKALAEMIA 1 0.0000
868 RENAL DISORDER 1 0.0000
869 BLOOD CHOLESTEROL INCREASED 1 0.0000
870 CARDIAC DISORDER 2 0.0000
871 DRUG INEFFECTIVE 28 0.0000
872 PULMONARY EMBOLISM 2 0.0000
873 COMA 1 0.0000
874 DRY EYE 1 0.0000
875 FLUSHING 2 0.0000
876 THERAPY CESSATION 1 0.0000
877 ABDOMINAL PAIN UPPER 4 0.0000
878 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
879 NERVOUSNESS 1 0.0000
880 HAEMORRHAGE 2 0.0000
881 DERMATITIS ATOPIC 1 0.0000
882 PANCREATITIS 1 0.0000
883 DRUG DEPENDENCE 3 0.0000
884 DRUG EFFECT DECREASED 1 0.0000
885 DRUG DOSE OMISSION 3 0.0000
886 BLISTER 1 0.0000
887 TOXICITY TO VARIOUS AGENTS 3 0.0000
888 EYE PAIN 1 0.0000
889 MYALGIA 3 0.0000
890 DEPRESSION 4 0.0000
891 PRODUCT SUBSTITUTION ISSUE 1 0.0000
892 SURGERY 1 0.0000
893 CATARACT 1 0.0000
894 VERTIGO 1 0.0000
895 INTENTIONAL OVERDOSE 1 0.0000
896 RHINORRHOEA 1 0.0000
897 DEEP VEIN THROMBOSIS 1 0.0000
898 PRODUCT DOSE OMISSION 1 0.0000
899 INFUSION RELATED REACTION 1 0.0000
900 FEBRILE NEUTROPENIA 1 0.0000
901 NEOPLASM MALIGNANT 1 0.0000
902 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
903 SKIN BURNING SENSATION 1 0.0000
904 OVERDOSE 3 0.0000
905 UNDERDOSE 1 0.0000
906 UNEVALUABLE EVENT 1 0.0000
907 ACNE 1 0.0000
908 CHRONIC KIDNEY DISEASE 1 0.0000
909 CARDIAC FAILURE CONGESTIVE 1 0.0000
910 TREATMENT FAILURE 1 0.0000
911 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
912 RHEUMATOID ARTHRITIS 1 0.0000
913 RENAL FAILURE 1 0.0000
914 NEUTROPENIA 1 0.0000
915 MYOCARDIAL INFARCTION 1 0.0000
916 HYPOTENSION 1 0.0000